6-Bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine is a heterocyclic organic compound characterized by its complex bicyclic structure, which incorporates both pyrrole and pyrimidine rings. This compound features bromine and chlorine substituents, which significantly influence its chemical reactivity and physical properties. The presence of halogens typically enhances the compound's lipophilicity and can affect its biological activity, making it of interest in medicinal chemistry. It is often utilized in research related to pharmaceuticals, particularly in the development of kinase inhibitors or other therapeutic agents. The compound's molecular structure contributes to its potential interactions with biological targets, and its synthesis may involve various organic reactions, including halogenation and cyclization processes. Additionally, its stability and solubility characteristics are influenced by the substituents and the overall electronic configuration of the molecule. As with many halogenated compounds, safety precautions should be observed due to potential toxicity and environmental impact.

6-bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

1131992-30-7: 6-Bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine is a heterocyclic organic compound characterized by its complex bicyclic structure, which incorporates both pyrrole and pyrimidine rings. This compound features bromine and chlorine substituents, which significantly influence its chemical reactivity and physical properties. The presence of halogens typically enhances the compound's lipophilicity and can affect its biological activity, making it of interest in medicinal chemistry. It is often utilized in research related to pharmaceuticals, particularly in the development of kinase inhibitors or other therapeutic agents. The compound's molecular structure contributes to its potential interactions with biological targets, and its synthesis may involve various organic reactions, including halogenation and cyclization processes. Additionally, its stability and solubility characteristics are influenced by the substituents and the overall electronic configuration of the molecule. As with many halogenated compounds, safety precautions should be observed due to potential toxicity and environmental impact.

CAS 1131992-30-7

6-bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

6-bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

Ref: IN-DA0094R8

6-BROMO-2,4-DICHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE

Ref: 10-F502785